Patient group input submissions: Ocrelizumab (Ocrevus) (Hoffmann-La Roche Limited)
Corporate Authors: | , |
---|---|
Format: | eBook |
Language: | English |
Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2017, 2017
|
Series: | CADTH common drug review
|
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Item Description: | "Indication: Treatment of adult patients with relapsing-remitting multiple sclerosis (RRMS) with active disease defined by clinical and imaging features." |
---|---|
Physical Description: | 1 PDF file (5 pages) |